Hims & Hers Health
HIMS
141 hedge funds and large institutions have $592M invested in Hims & Hers Health in 2021 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 35 increasing their positions, 36 reducing their positions, and 17 closing their positions.
171% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 17
25% more capital invested
Capital invested by funds: $473M → $592M (+$119M)
25% more funds holding
Funds holding: 113 → 141 (+28)
14.07% more ownership
Funds ownership: 32.19% → 46.26% (+14%)
14% more call options, than puts
Call options by funds: $5.49M | Put options by funds: $4.83M
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
3% less repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 36
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
+$7.56M |
| 2 |
FCMV
Foresite Capital Management V
Larkspur,
California
|
+$4.7M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$4.58M |
| 4 |
Millennium Management
New York
|
+$3.05M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.02M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Royce & Associates
New York
|
-$4.63M |
| 2 |
DI
DUMAC Inc
Durham,
North Carolina
|
-$4.52M |
| 3 |
Morgan Stanley
New York
|
-$4.37M |
| 4 |
Renaissance Technologies
New York
|
-$3.77M |
| 5 |
Goldman Sachs
New York
|
-$2.91M |
HIMS Hedge Fund Activity: Q4 2021 in Review
141 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Hims & Hers Health (HIMS) for Q4 2021, worth a combined $592M — up 25% from $473M a quarter earlier.
Buyers outnumbered sellers: 46 funds opened new HIMS positions and 17 closed out — a net gain of 29 holders — while 35 added to existing stakes and 36 trimmed.
The largest buyer was Two Sigma Investments, opening a new position worth an estimated $7.56M. The largest seller was Royce & Associates, cutting an estimated $4.63M.
- 141 institutional investors held Hims & Hers Health (HIMS) as of Q4 2021, up from 113 in Q3 2021.
- Funds reported $592M of Hims & Hers Health stock for Q4 2021, up 25% quarter-over-quarter.
- 46 funds opened new Hims & Hers Health positions in Q4 2021 and 17 closed out, a net change of +29 holders.
- The largest Hims & Hers Health buyer in Q4 2021 was Two Sigma Investments, an estimated $7.56M added.
- The largest Hims & Hers Health seller in Q4 2021 was Royce & Associates, an estimated $4.63M sold.
Based on aggregated 13F filings for Q4 2021.